Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences
Key Highlights
- ➤Fate Therapeutics (FATE) to participate in two fourth-quarter 2026 healthcare conferences
- ➤Jefferies Global Healthcare Conference scheduled November 16–19 in London
- ➤Piper Sandler 38th Annual Healthcare Conference scheduled December 1–3 in New York
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that management will participate in the following investor conferences in the fourth quarter of 2026.
The Company may participate in a presentation or a fireside chat at these conferences. When available, a live webcast will be accessible under “Events & Presentations” on the Investors section of the Company’s website at www.fatetherapeutics.com. An archived replay of the webcast will be available for 30 days following the event.
Get started
Create a free account to read the full story.